While both strains of E. coli localized to the tumor, gemcitabine prevented tumor growth only in mice treated with E. coli Δcdd, supporting the hypothesis that intratumoral bacterial cdd interferes with fluoropyrimidine efficacy in vivo (65). This evidence concerns the gene CDA and neoplasm.